# Blue Bees Therapeutics

> Innovative cancer immunotherapy technology

Business model and tags: Pharma & life sciences, Has in-house R&D

## About Blue Bees Therapeutics

Development of first-in-class immunotherapies targeting cancer by stimulating anti-tumor immune response through novel antibody technology.

## Key facts

- **Industry**: Biotechnology
- **Company size**: 11–50 employees
- **Headquarters**: Orsay, Île-de-France, France
- **Founded**: 2022
- **Revenue**: €3.9M – €30.6M (Tamtam estimate)
- **SIREN**: [911407757](https://annuaire-entreprises.data.gouv.fr/entreprise/911407757)
- **Website**: [bbtx.fr](https://www.bbtx.fr)
- **LinkedIn**: [linkedin.com/company/blue-bees-therapeutics](https://www.linkedin.com/company/blue-bees-therapeutics)

## Blue Bees Therapeutics at a glance

Blue Bees Therapeutics is a company in the Biotechnology industry, headquartered in Orsay, Île-de-France, France.

Blue Bees Therapeutics was founded in 2022.

Blue Bees Therapeutics has 11–50 employees.

Blue Bees Therapeutics's revenue is €3.9M – €30.6M (Tamtam estimate).

Blue Bees Therapeutics's SIREN number is 911407757.

## Frequently asked questions about Blue Bees Therapeutics

### What is Blue Bees Therapeutics's revenue?

Tamtam estimates Blue Bees Therapeutics's annual revenue at €3.9M – €30.6M.

### How many employees does Blue Bees Therapeutics have?

Blue Bees Therapeutics has 11–50 employees.

### Where is Blue Bees Therapeutics headquartered?

Blue Bees Therapeutics is headquartered in Orsay, Île-de-France, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/blue-bees-therapeutics